222 related articles for article (PubMed ID: 3309088)
1. Treatment of chronic erythema nodosum leprosum with cyclosporine A produces clinical and immunohistologic remission.
Miller RA; Shen JY; Rea TH; Harnisch JP
Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):441-9. PubMed ID: 3309088
[TBL] [Abstract][Full Text] [Related]
2. Effect of cyclosporine A in erythema nodosum leprosum.
Uyemura K; Dixon JF; Wong L; Rea TH; Modlin RL
J Immunol; 1986 Dec; 137(11):3620-3. PubMed ID: 2946765
[TBL] [Abstract][Full Text] [Related]
3. [Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study].
de Carsalade GY; Achirafi A; Flageul B
Acta Leprol; 2003; 12(3):117-22. PubMed ID: 15040702
[TBL] [Abstract][Full Text] [Related]
4. A follow up of T-cell subsets and of anti-M. leprae antibody titer as measured by the FLA-ABS test in Melanesian leprosy patients under polychemotherapy.
Garraud O; Ribierre O; Bach MA
Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):38-45. PubMed ID: 2940306
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to mycobacterial arabinomannan in leprosy: correlation with reactional states and variation during treatment.
Miller RA; Harnisch JP; Buchanan TM
Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):133-9. PubMed ID: 6373624
[TBL] [Abstract][Full Text] [Related]
6. In situ identification of activated Ta1+ T lymphocytes in human leprosy skin lesions.
Shen JY; Hofman FM; Gunter JR; Modlin RL; Rea TH
Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):494-8. PubMed ID: 2443587
[TBL] [Abstract][Full Text] [Related]
7. Enhanced cell-mediated immune responses in erythema nodosum leprosum reactions of leprosy.
Rao TD; Rao PR
Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):36-41. PubMed ID: 3549939
[TBL] [Abstract][Full Text] [Related]
8. Changes in circulating antibody levels to the major phenolic glycolipid during erythema nodosum leprosum in leprosy patients.
Andreoli A; Brett SJ; Draper P; Payne SN; Rook GA
Int J Lepr Other Mycobact Dis; 1985 Jun; 53(2):211-7. PubMed ID: 3894538
[TBL] [Abstract][Full Text] [Related]
9. IgM antibodies against phenolic glycolipid I from Mycobacterium leprae in leprosy sera: relationship to bacterial index and erythema nodosum leprosum.
Schwerer B; Meeker HC; Sersen G; Levis WR
Acta Leprol; 1984; 2(2-4):394-402. PubMed ID: 6398598
[TBL] [Abstract][Full Text] [Related]
10. In situ characterization of T lymphocyte subsets in the reactional states of leprosy.
Modlin RL; Gebhard JF; Taylor CR; Rea TH
Clin Exp Immunol; 1983 Jul; 53(1):17-24. PubMed ID: 6223731
[TBL] [Abstract][Full Text] [Related]
11. Studies of human leprosy lesions in situ using suction-induced blisters: cell changes with IgM antibody to PGL-1 and interleukin-2 receptor in clinical subgroups of erythema nodosum leprosum.
Bhoopat L; Scollard DM; Theetranont C; Chiewchanvit S; Nelson DL; Utaipat U
Asian Pac J Allergy Immunol; 1991 Dec; 9(2):107-19. PubMed ID: 1807258
[TBL] [Abstract][Full Text] [Related]
12. Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide.
Feuth M; Brandsma JW; Faber WR; Bhattarai B; Feuth T; Anderson AM
Lepr Rev; 2008 Sep; 79(3):254-69. PubMed ID: 19009975
[TBL] [Abstract][Full Text] [Related]
13. In situ and in vitro characterization of the cellular immune response in erythema nodosum leprosum.
Modlin RL; Mehra V; Jordan R; Bloom BR; Rea TH
J Immunol; 1986 Feb; 136(3):883-6. PubMed ID: 2416837
[TBL] [Abstract][Full Text] [Related]
14. Tissue and blood T-lymphocyte subpopulations in erythema nodosum leprosum.
Modlin RL; Bakke AC; Vaccaro SA; Horwitz DA; Taylor CR; Rea TH
Arch Dermatol; 1985 Feb; 121(2):216-9. PubMed ID: 3156560
[TBL] [Abstract][Full Text] [Related]
15. Increased activated memory B-cells in the peripheral blood of patients with erythema nodosum leprosum reactions.
Negera E; Walker SL; Bekele Y; Dockrell HM; Lockwood DN
PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006121. PubMed ID: 29253897
[TBL] [Abstract][Full Text] [Related]
16. Thalidomide--effect on T cell subsets as a possible mechanism of action.
Moncada B; Baranda ML; González-Amaro R; Urbina R; Loredo CE
Int J Lepr Other Mycobact Dis; 1985 Jun; 53(2):201-5. PubMed ID: 3874920
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous upgrading reaction and erythema nodosum leprosum in a patient with lepromatous leprosy.
Job CK; Jacobson RR; Hastings RC
Int J Lepr Other Mycobact Dis; 1988 Sep; 56(3):437-42. PubMed ID: 3418207
[TBL] [Abstract][Full Text] [Related]
18. Tr, T mu and B lymphocytes in erythema nodosum leprosum reactions of leprosy.
Rao TD; Rao PR
Indian J Lepr; 1986; 58(4):601-8. PubMed ID: 2952738
[TBL] [Abstract][Full Text] [Related]
19. Imbalances in T cell subpopulations in lepromatous leprosy.
Wallach D; Cottenot F; Bach MA
Int J Lepr Other Mycobact Dis; 1982 Sep; 50(3):282-90. PubMed ID: 6216219
[TBL] [Abstract][Full Text] [Related]
20. Thymus dependent lymphocytes in leprosy. I. T lymphocyte subpopulations defined by monoclonal antibodies.
Mshana RN; Haregewoin A; Harboe M; Belehu A
Int J Lepr Other Mycobact Dis; 1982 Sep; 50(3):291-6. PubMed ID: 6216220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
